Grade 2 Glioma research hub

Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)

This study is for people with a specific type of brain tumour called Grade 2 glioma, which has come back or wasn't fully removed by surgery. It's testing a new drug called vorasidenib against a dummy pill to see if it can help stop the tumour from growing.